MedPath

Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy

Not Applicable
Completed
Conditions
Knee Arthroscopy
Interventions
Registration Number
NCT00803725
Lead Sponsor
University Health Network, Toronto
Brief Summary

The purpose of this study is to determine if the addition of intrathecal fentanyl to low dose mepivacaine spinal anesthesia provides adequate surgical anesthesia with shorter duration of motor blockade.

It is hypothesized that lower doses of spinal mepivacaine when combined with fentanyl will result in adequate surgical block for knee arthroscopy surgery with faster recovery and discharge compared to mepivacaine alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  1. Patients having unilateral arthroscopic surgery of the knee;
  2. ASA I-III status;
  3. Age 18-80 years;
  4. BMI< 35.
Read More
Exclusion Criteria
  1. Patients who have previous history of hypersensitivity to local anesthetics or contraindications for spinal anesthesia (i.e. bleeding diathesis, coagulopathy);
  2. Patients with radiating low back pain and neurological deficits in lower extremities;
  3. Patients who are incapable of giving an informed consent.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Mepivacaine without fentanylMepivicaine for spinal anesthesia
2Mepivacaine with FentanylMepivacaine with Fentanyl for spinal anesthesia
Primary Outcome Measures
NameTimeMethod
Time to complete motor block regression (0) as measured by modified Bromage scale.Every 2 minutes from administration of the spinal until complete onset.
Secondary Outcome Measures
NameTimeMethod
Block success, peak, and duration; time to ambulation, urination, discharge; incidence of adverse events.Up to 72 hours after surgery.

Trial Locations

Locations (1)

Toronto Western Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath